1.
Wolthers OD: Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma. Pediatr Allergy Immunol 2003;14:248-254.
2.
Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, Seveus L, Trulson A: Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999;29:1172-1186.
3.
Young JD, Peterson CG, Venge P, Cohn ZA: Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 1986;321:613-616.
4.
Imai C, Yamazaki H, Tanaka Y, Matsunaga M, Numata O, Torigoe K: Ratio of eosinophil cationic protein/eosinophil count as a new marker in children with acute asthma. Pediatr Int 1999;41:142-146.
5.
Fujitaka M, Kawaguchi H, Kato Y, Sakura N, Ueda K, Abe Y: Significance of the eosinophil cationic protein/eosinophil count ratio in asthmatic patients: its relationship to disease severity. Ann Allergy Asthma Immunol 2001;86:323-329.
6.
Huang CS, Chen SJ, Chung RL, Tang RB: Serum interleukin-5 measurements for monitoring acute asthma in children. J Asthma 2005;42:297-300.
7.
Oymar K, Elsayed S, Bjerknes R: Serum eosinophil cationic protein and interleukin-5 in children with bronchial asthma and acute bronchiolitis. Pediatr Allergy Immunol 1996;7:180-186.
8.
Kato M, Yamada Y, Maruyama K, Hayashi Y: Serum eosinophil cationic protein and 27 cytokines/chemokines in acute exacerbation of childhood asthma. Int Arch Allergy Immunol 2010;152(suppl 1):62-66.
9.
Batra J, Chatterjee R, Ghosh B: Inducible nitric oxide synthase (iNOS): role in asthma pathogenesis. Indian J Biochem Biophys 2007;44:303-309.
10.
Wang CH, Hsieh WY, Shih LY, Lin HC, Liu CY, Chung KF, Kuo HP: Increased progenitor cell proliferation in the peripheral blood of patients with bronchial asthma: the role of nitric oxide. J Allergy Clin Immunol 1999;104:803-810.
11.
Banovcin P, Jesenak M, Michnova Z, Babusikova E, Nosal S, Mikler J, Fabry J, Barreto M: Factors attributable to the level of exhaled nitric oxide in asthmatic children. Eur J Med Res 2009;14(suppl 4):9-13.
12.
Jang AS, Choi IS: Nitric oxide metabolites in patients with asthma: induced sputum versus blood. Respir Med 1999;93:912-918.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.